ARTIVION, INC. (AORT)

Data as of Sep 11, 2026, from SEC Form 4 filings.

XNYSSURGICAL & MEDICAL INSTRUMENTS & APPARATUSNet insider selling (90d)Watch AORT

See up to 3 months of AORT. The 7-day demo opens the 1M and 3M ranges and puts AORT on your watchlist.

Latest AORT insider trades

Andrew M. Green - Officer
Open-market sale$287K
Sep 10, 2026
Andrew M. Green - Officer

About ARTIVION, INC. (AORT)

Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.

Headquarters: KENNESAW, GA
Employees: 1,800
Listed: 1993
Exchange: XNYS
Sector: Health Care

https://www.artivion.com SEC filings for AORT on EDGAR

AORT Form 4 activity by transaction type, last 90 days

Form 4 transaction type	Transactions	Shares	Total value
Open-market sale	7	91,791	$2.60M

AORT insider transactions (Form 4)

67 Form 4 filings on record, the earliest from Oct 2, 2024, newest first. Filing history page 1 of 3.

Date	Insider	Transaction	Security	Shares	Price	Value
Sep 10, 2026	Andrew M. Green - Officer	Open-market sale	Common Stock	11,480	$24.97^{footnote F1}	$287K
Footnote F1 (price): Reflects weighted average price. Range of prices were between $24.840 to $25.235. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Sep 2, 2026	Andrew M. Green - Officer	Open-market sale	Common Stock	6,510	$27.27^{footnote F1}	$177K
Sep 3, 2026	Andrew M. Green - Officer	Open-market sale	Common Stock	1,493	$26.02^{footnote F2}	$39K
Footnote F1 (price): Reflects weighted average price. Range of prices were between $27.000 to $27.760. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Footnote F2 (price): Reflects weighted average price. Range of prices were between $26.000 to $26.040. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Aug 19, 2026	James P. Mackin - Officer	Open-market sale	Common Stock	70,000	$28.96^{footnote F1}	$2.03M
Footnote F1 (price): Reflects weighted average price. Range of prices were between $28.89 to $29.15. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Aug 14, 2026	Andrew M. Green - Officer	Open-market sale	Common Stock	616^{footnote F1}	$28.55	$18K
Footnote F1 (shares): These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.
Aug 14, 2026	Lance A. Berry - Officer	Open-market sale	Common Stock	715^{footnote F1}	$28.55	$20K
Footnote F1 (shares): These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.
Aug 12, 2026	Jean F. Holloway - Officer	Open-market sale	Common Stock	977	$28.49^{footnote F1}	$28K
Footnote F1 (price): Reflects the price the shares were sold.
Jun 11, 2026	Andrew M. Green - Officer	Option exercise	Stock Options (Right to buy)	14,001^{footnote F1}	$0.00	-
Jun 11, 2026	Andrew M. Green - Officer	Option exercise	Stock Options (Right to buy)	30,000^{footnote F1}	$0.00	-
Jun 11, 2026	Andrew M. Green - Officer	Option exercise	Common Stock	14,001^{footnote F1}	$18.44	$258K
Jun 11, 2026	Andrew M. Green - Officer	Open-market sale	Common Stock	14,001^{footnote F1}	$20.71^{footnote F2}	$290K
Jun 11, 2026	Andrew M. Green - Officer	Option exercise	Common Stock	30,000^{footnote F1}	$11.03	$331K
Jun 11, 2026	Andrew M. Green - Officer	Open-market sale	Common Stock	30,000^{footnote F1}	$20.69^{footnote F3}	$621K
Footnote F1 (shares): The option exercise and subsequent sale reported on this form were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2026. Footnote F2 (price): Reflects weighted average price. Range of prices were between $20.25 to $21.02. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Footnote F3 (price): Reflects weighted average price. Range of prices were between $20.24 to $21.02. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Jun 2, 2026	Anthony B. Semedo - Director	Other	Common Stock	6,325^{footnote F1}	$0.00	-
Jun 2, 2026	Anthony B. Semedo - Director	Other	Common Stock	6,325^{footnote F1}	$0.00	-
Footnote F1 (shares): Represents a transfer of shares from the Reporting Person's directly held account to an account held by the Stacie Nelson and Anthony Semedo Living Trust. The transfer was made for estate planning purposes, involved no sale or other disposition for value, and resulted only in a… Full note on SEC EDGAR
May 18, 2026	Marna P. Borgstrom - Director	Grant or award	Common Stock	7,576	$0.00	-
May 18, 2026	Anthony B. Semedo - Director	Grant or award	Common Stock	7,576^{footnote F1}	$0.00	-
Footnote F1 (shares): RSA Grant vests on May 18, 2027, pursuant to the terms of the Equity and Cash Incentive Plan.
May 18, 2026	Jon W. Salveson - Director	Grant or award	Common Stock	7,576^{footnote F1}	$0.00	-
Footnote F1 (shares): RSA Grant vests on May 18, 2027, pursuant to the terms of the Equity and Cash Incentive Plan.
May 18, 2026	Elizabeth A. Hoff - Director	Grant or award	Common Stock	7,576^{footnote F1}	$0.00	-
Footnote F1 (shares): RSA Grant vests on May 18, 2027, pursuant to the terms of the Equity and Cash Incentive Plan.
May 18, 2026	Jeffrey H. Burbank - Director	Grant or award	Common Stock	7,576^{footnote F1}	$0.00	-
Footnote F1 (shares): RSA Grant vests on May 18, 2027, pursuant to the terms of the Equity and Cash Incentive Plan.
May 18, 2026	James Bullock - Director	Grant or award	Common Stock	7,576^{footnote F1}	$0.00	-
Footnote F1 (shares): RSA Grant vests on May 18, 2027, pursuant to the terms of the Equity and Cash Incentive Plan.
May 18, 2026	Daniel J. Bevevino - Director	Grant or award	Common Stock	7,576^{footnote F1}	$0.00	-
Footnote F1 (shares): RSA Grant vests on May 18, 2027, pursuant to the terms of the Equity and Cash Incentive Plan.
May 18, 2026	Thomas F. Ackerman - Director	Grant or award	Common Stock	7,576^{footnote F1}	$0.00	-
Footnote F1 (shares): RSA Grant vests on May 18, 2027, pursuant to the terms of the Equity and Cash Incentive Plan.
May 14, 2026	Marna P. Borgstrom - Director	Grant or award	Common Stock	7,850^{footnote F1}	$0.00	-
Footnote F1 (shares): RSA Grant vests on May 14, 2027, pursuant to the terms of the Equity and Cash Incentive Plan.
Mar 2, 2026	Amy Horton - Officer	Grant or award	Common Stock	7,475^{footnote F1}	$0.00	-
Mar 3, 2026	Amy Horton - Officer	Open-market sale	Common Stock	901^{footnote F2}	$37.78	$34K
Footnote F1 (shares): Represents performance stock units granted on February 28, 2025. One third (1/3) were issued on March 2, 2026. The remaining shares earned in connection with the February 2025 grant will be eligible to vest and be issued as follows: one third (1/3) on February 28, 2027; and one… Full note on SEC EDGAR Footnote F2 (shares): These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.
Mar 4, 2026	Jean F. Holloway - Officer	Open-market sale	Common Stock	8,962	$38.00^{footnote F3}	$341K
Mar 2, 2026	Jean F. Holloway - Officer	Grant or award	Common Stock	27,795^{footnote F1}	$0.00	-
Mar 3, 2026	Jean F. Holloway - Officer	Open-market sale	Common Stock	3,843^{footnote F2}	$37.78	$145K
Footnote F1 (shares): Represents performance stock units granted on February 28, 2025. One third (1/3) were issued on March 2, 2026. The remaining shares earned in connection with the February 2025 grant will be eligible to vest and be issued as follows: one third (1/3) on February 28, 2027; and one… Full note on SEC EDGAR Footnote F2 (shares): These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. Footnote F3 (price): Reflects the price the shares were sold.
Mar 2, 2026	Marshall S. Stanton - Officer	Grant or award	Common Stock	21,838^{footnote F1}	$0.00	-
Mar 3, 2026	Marshall S. Stanton - Officer	Open-market sale	Common Stock	2,149^{footnote F2}	$37.78	$81K
Footnote F1 (shares): Represents performance stock units granted on February 28, 2025. One third (1/3) were issued on March 2, 2026. The remaining shares earned in connection with the February 2025 grant will be eligible to vest and be issued as follows: one third (1/3) on February 28, 2027; and one… Full note on SEC EDGAR Footnote F2 (shares): These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.
Mar 2, 2026	John E. Davis - Officer	Grant or award	Common Stock	28,845^{footnote F1}	$0.00	-
Mar 3, 2026	John E. Davis - Officer	Open-market sale	Common Stock	4,573^{footnote F2}	$37.78	$173K
Footnote F1 (shares): Represents performance stock units granted on February 28, 2025. One third (1/3) were issued on March 2, 2026. The remaining shares earned in connection with the February 2025 grant will be eligible to vest and be issued as follows: one third (1/3) on February 28, 2027; and one… Full note on SEC EDGAR Footnote F2 (shares): These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.
Mar 2, 2026	Lance A. Berry - Officer	Grant or award	Common Stock	40,874^{footnote F1}	$0.00	-
Mar 3, 2026	Lance A. Berry - Officer	Open-market sale	Common Stock	6,316^{footnote F2}	$37.78	$239K
Footnote F1 (shares): Represents performance stock units granted on February 28, 2025. One third (1/3) were issued on March 2, 2026. The remaining shares earned in connection with the February 2025 grant will be eligible to vest and be issued as follows: one third (1/3) on February 28, 2027; and one… Full note on SEC EDGAR Footnote F2 (shares): These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.
Mar 2, 2026	James P. Mackin - Officer	Grant or award	Common Stock	116,948^{footnote F1}	$0.00	-
Mar 3, 2026	James P. Mackin - Officer	Open-market sale	Common Stock	17,887^{footnote F2}	$37.78	$676K
Footnote F1 (shares): Represents performance stock units granted on February 28, 2025. One third (1/3) were issued on March 2, 2026. The remaining shares earned in connection with the February 2025 grant will be eligible to vest and be issued as follows: one third (1/3) on February 28, 2027; and one… Full note on SEC EDGAR Footnote F2 (shares): These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.
Mar 2, 2026	Amy Horton - Officer	Open-market sale	Common Stock	641^{footnote F1}	$38.02	$24K
Footnote F1 (shares): These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.
Mar 2, 2026	Marshall S. Stanton - Officer	Open-market sale	Common Stock	1,513^{footnote F1}	$38.02	$58K
Footnote F1 (shares): These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.
Mar 2, 2026	James P. Mackin - Officer	Open-market sale	Common Stock	14,911^{footnote F1}	$38.02	$567K
Footnote F1 (shares): These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.
Mar 2, 2026	Jean F. Holloway - Officer	Open-market sale	Common Stock	2,183^{footnote F1}	$38.02	$83K
Footnote F1 (shares): These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.
Mar 2, 2026	Lance A. Berry - Officer	Open-market sale	Common Stock	5,178^{footnote F1}	$38.02	$197K
Footnote F1 (shares): These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.
Mar 2, 2026	John E. Davis - Officer	Open-market sale	Common Stock	2,784^{footnote F1}	$38.02	$106K
Footnote F1 (shares): These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.
Feb 23, 2026	Amy Horton - Officer	Open-market sale	Common Stock	1,731^{footnote F1}	$37.59	$65K
Feb 24, 2026	Amy Horton - Officer	Open-market sale	Common Stock	830^{footnote F2}	$35.69	$30K
Feb 24, 2026	Amy Horton - Officer	Grant or award	Common Stock	5,658^{footnote F3}	$0.00	-
Footnote F1 (shares): These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. Footnote F2 (shares): These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. Footnote F3 (shares): Represents shares of restricted stock that vest 33 1/3% per year beginning on the first anniversary of the grant date, pursuant to the terms of the Equity and Cash Incentive Plan.

Recent AORT Form 8-K filings

Read AORT company news

Aug 6, 2026Item 2.02, 9.01

Read the filing on SEC EDGAR

May 18, 2026Item 7.01, 8.01, 9.01

Read the filing on SEC EDGAR

May 15, 2026Item 5.07

Read the filing on SEC EDGAR

May 7, 2026Item 1.01, 2.02, 9.01

Recent AORT Form 144 notices of proposed sale

An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.

Filed	Filer	Relationship	Shares	Market value	Notice
Sep 10, 2026	GREEN ANDREW M	Officer	11,480	$287K	View on EDGAR
Sep 3, 2026	GREEN ANDREW M	Officer	1,493	$39K

Congress trades in AORT

All congress trades

Stock trades in AORT disclosed by members of the U.S. House in the last 12 months, newest first. Values are the ranges as filed.

Member	Type	Traded	Disclosed	Value range	Owner	Days to disclose	Filing
Gilbert Ray Cisneros, Jr.Democrat, CA-31	Purchase

AORT insider trading FAQ

What is the latest insider trade for AORT?

ARTIVION, INC. (AORT) had 6 insider filings in the last 90 days, with the most recent on 2026-09-11. The full record for AORT runs to 67 Form 4 filings, the earliest from 2024-10-02. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.

How many insiders are buying AORT stock?

No insider purchases of AORT were filed in the last 90 days.

How many insiders are selling AORT stock?

7 insider sales of AORT were filed in the last 90 days, totaling $2.60M.

Where can I see AORT SEC filings (Form 4, 10-K, 10-Q, 8-K)?

This page collects AORT Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.

More Health Care companies with insider activity

Recent insider filings

The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.

Sep 11, 2026 - Andrew M. Green view on EDGAR
Sep 4, 2026 - Andrew M. Green view on EDGAR
Aug 20, 2026 - James P. Mackin view on EDGAR
Aug 17, 2026 - Andrew M. Green view on EDGAR
Aug 17, 2026 - Lance A. Berry view on EDGAR
Aug 12, 2026 - Jean F. Holloway view on EDGAR
Jun 15, 2026 - Andrew M. Green view on EDGAR
Jun 4, 2026 - Anthony B. Semedo view on EDGAR
May 21, 2026 - Marna P. Borgstrom view on EDGAR

Related companies with recent insider activity

Learn more

Insider selling: signal or noise?: Why most insider sales are routine, and the few patterns worth a second look.
Form 144 vs Form 4: A Form 144 announces a planned sale; the Form 4 reports it after it happens.
Insider activity in Health Care: Where AORT's peers are being bought and sold.
Every recent Form 4: The market-wide feed, updated as filings arrive from SEC EDGAR.

Follow AORT with a 7-day demo

AORT on your watchlist
Every AORT Form 4 filing on record
Up to 3 months of AORT price history
The daily trading plan of ranked insider buys, on a delay, with the plan archive

Start 7-day demoCard required. Your card is never charged for the demo.

Form 4 transaction type

Transactions

Total value

Open-market sale

91,791

$2.60M

Date

Insider

Transaction

Security

Price

Value

Sep 10, 2026

Andrew M. Green - Officer

Open-market sale

Common Stock

11,480

$24.97^{footnote F1}

$287K

Footnote F1 (price): Reflects weighted average price. Range of prices were between $24.840 to $25.235. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Sep 2, 2026

Andrew M. Green - Officer

Open-market sale

Common Stock

6,510

$27.27^{footnote F1}

$177K

Sep 3, 2026

Andrew M. Green - Officer

Open-market sale

Common Stock

1,493

$26.02^{footnote F2}

$39K

Footnote F1 (price): Reflects weighted average price. Range of prices were between $27.000 to $27.760. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Footnote F2 (price): Reflects weighted average price. Range of prices were between $26.000 to $26.040. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Aug 19, 2026

James P. Mackin - Officer

Open-market sale

Common Stock

70,000

$28.96^{footnote F1}

$2.03M

Footnote F1 (price): Reflects weighted average price. Range of prices were between $28.89 to $29.15. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Aug 14, 2026

Andrew M. Green - Officer

Open-market sale

Common Stock

616^{footnote F1}

$28.55

$18K

Footnote F1 (shares): These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

Aug 14, 2026

Lance A. Berry - Officer

Open-market sale

Common Stock

715^{footnote F1}

$28.55

$20K

Footnote F1 (shares): These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

Aug 12, 2026

Jean F. Holloway - Officer

Open-market sale

Common Stock

977

$28.49^{footnote F1}

$28K

Footnote F1 (price): Reflects the price the shares were sold.

Jun 11, 2026

Andrew M. Green - Officer

Option exercise

Stock Options (Right to buy)

14,001^{footnote F1}

$0.00

Jun 11, 2026

Andrew M. Green - Officer

Option exercise

Stock Options (Right to buy)

30,000^{footnote F1}

$0.00

Jun 11, 2026

Andrew M. Green - Officer

Option exercise

Common Stock

14,001^{footnote F1}

$18.44

$258K

Jun 11, 2026

Andrew M. Green - Officer

Open-market sale

Common Stock

14,001^{footnote F1}

$20.71^{footnote F2}

$290K

Jun 11, 2026

Andrew M. Green - Officer

Option exercise

Common Stock

30,000^{footnote F1}

$11.03

$331K

Jun 11, 2026

Andrew M. Green - Officer

Open-market sale

Common Stock

30,000^{footnote F1}

$20.69^{footnote F3}

$621K

Footnote F1 (shares): The option exercise and subsequent sale reported on this form were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2026.
Footnote F2 (price): Reflects weighted average price. Range of prices were between $20.25 to $21.02. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Footnote F3 (price): Reflects weighted average price. Range of prices were between $20.24 to $21.02. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Jun 2, 2026

Anthony B. Semedo - Director

Other

Common Stock

6,325^{footnote F1}

$0.00

Jun 2, 2026

Anthony B. Semedo - Director

Other

Common Stock

6,325^{footnote F1}

$0.00

Footnote F1 (shares): Represents a transfer of shares from the Reporting Person's directly held account to an account held by the Stacie Nelson and Anthony Semedo Living Trust. The transfer was made for estate planning purposes, involved no sale or other disposition for value, and resulted only in a… Full note on SEC EDGAR

May 18, 2026

Marna P. Borgstrom - Director

Grant or award

Common Stock

7,576

$0.00

May 18, 2026

Anthony B. Semedo - Director

Grant or award

Common Stock

7,576^{footnote F1}

$0.00

Footnote F1 (shares): RSA Grant vests on May 18, 2027, pursuant to the terms of the Equity and Cash Incentive Plan.

May 18, 2026

Jon W. Salveson - Director

Grant or award

Common Stock

7,576^{footnote F1}

$0.00

Footnote F1 (shares): RSA Grant vests on May 18, 2027, pursuant to the terms of the Equity and Cash Incentive Plan.

May 18, 2026

Elizabeth A. Hoff - Director

Grant or award

Common Stock

7,576^{footnote F1}

$0.00

Footnote F1 (shares): RSA Grant vests on May 18, 2027, pursuant to the terms of the Equity and Cash Incentive Plan.

May 18, 2026

Jeffrey H. Burbank - Director

Grant or award

Common Stock

7,576^{footnote F1}

$0.00

Footnote F1 (shares): RSA Grant vests on May 18, 2027, pursuant to the terms of the Equity and Cash Incentive Plan.

May 18, 2026

James Bullock - Director

Grant or award

Common Stock

7,576^{footnote F1}

$0.00

Footnote F1 (shares): RSA Grant vests on May 18, 2027, pursuant to the terms of the Equity and Cash Incentive Plan.

May 18, 2026

Daniel J. Bevevino - Director

Grant or award

Common Stock

7,576^{footnote F1}

$0.00

Footnote F1 (shares): RSA Grant vests on May 18, 2027, pursuant to the terms of the Equity and Cash Incentive Plan.

May 18, 2026

Thomas F. Ackerman - Director

Grant or award

Common Stock

7,576^{footnote F1}

$0.00

Footnote F1 (shares): RSA Grant vests on May 18, 2027, pursuant to the terms of the Equity and Cash Incentive Plan.

May 14, 2026

Marna P. Borgstrom - Director

Grant or award

Common Stock

7,850^{footnote F1}

$0.00

Footnote F1 (shares): RSA Grant vests on May 14, 2027, pursuant to the terms of the Equity and Cash Incentive Plan.

Mar 2, 2026

Amy Horton - Officer

Grant or award

Common Stock

7,475^{footnote F1}

$0.00

Mar 3, 2026

Amy Horton - Officer

Open-market sale

Common Stock

901^{footnote F2}

$37.78

$34K

Footnote F1 (shares): Represents performance stock units granted on February 28, 2025. One third (1/3) were issued on March 2, 2026. The remaining shares earned in connection with the February 2025 grant will be eligible to vest and be issued as follows: one third (1/3) on February 28, 2027; and one… Full note on SEC EDGAR
Footnote F2 (shares): These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

Mar 4, 2026

Jean F. Holloway - Officer

Open-market sale

Common Stock

8,962

$38.00^{footnote F3}

$341K

Mar 2, 2026

Jean F. Holloway - Officer

Grant or award

Common Stock

27,795^{footnote F1}

$0.00

Mar 3, 2026

Jean F. Holloway - Officer

Open-market sale

Common Stock

3,843^{footnote F2}

$37.78

$145K

Footnote F1 (shares): Represents performance stock units granted on February 28, 2025. One third (1/3) were issued on March 2, 2026. The remaining shares earned in connection with the February 2025 grant will be eligible to vest and be issued as follows: one third (1/3) on February 28, 2027; and one… Full note on SEC EDGAR
Footnote F2 (shares): These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.
Footnote F3 (price): Reflects the price the shares were sold.

Mar 2, 2026

Marshall S. Stanton - Officer

Grant or award

Common Stock

21,838^{footnote F1}

$0.00

Mar 3, 2026

Marshall S. Stanton - Officer

Open-market sale

Common Stock

2,149^{footnote F2}

$37.78

$81K

Footnote F1 (shares): Represents performance stock units granted on February 28, 2025. One third (1/3) were issued on March 2, 2026. The remaining shares earned in connection with the February 2025 grant will be eligible to vest and be issued as follows: one third (1/3) on February 28, 2027; and one… Full note on SEC EDGAR
Footnote F2 (shares): These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

Mar 2, 2026

John E. Davis - Officer

Grant or award

Common Stock

28,845^{footnote F1}

$0.00

Mar 3, 2026

John E. Davis - Officer

Open-market sale

Common Stock

4,573^{footnote F2}

$37.78

$173K

Footnote F1 (shares): Represents performance stock units granted on February 28, 2025. One third (1/3) were issued on March 2, 2026. The remaining shares earned in connection with the February 2025 grant will be eligible to vest and be issued as follows: one third (1/3) on February 28, 2027; and one… Full note on SEC EDGAR
Footnote F2 (shares): These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

Mar 2, 2026

Lance A. Berry - Officer

Grant or award

Common Stock

40,874^{footnote F1}

$0.00

Mar 3, 2026

Lance A. Berry - Officer

Open-market sale

Common Stock

6,316^{footnote F2}

$37.78

$239K

Footnote F1 (shares): Represents performance stock units granted on February 28, 2025. One third (1/3) were issued on March 2, 2026. The remaining shares earned in connection with the February 2025 grant will be eligible to vest and be issued as follows: one third (1/3) on February 28, 2027; and one… Full note on SEC EDGAR
Footnote F2 (shares): These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

Mar 2, 2026

James P. Mackin - Officer

Grant or award

Common Stock

116,948^{footnote F1}

$0.00

Mar 3, 2026

James P. Mackin - Officer

Open-market sale

Common Stock

17,887^{footnote F2}

$37.78

$676K

Footnote F1 (shares): Represents performance stock units granted on February 28, 2025. One third (1/3) were issued on March 2, 2026. The remaining shares earned in connection with the February 2025 grant will be eligible to vest and be issued as follows: one third (1/3) on February 28, 2027; and one… Full note on SEC EDGAR
Footnote F2 (shares): These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

Mar 2, 2026

Amy Horton - Officer

Open-market sale

Common Stock

641^{footnote F1}

$38.02

$24K

Footnote F1 (shares): These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

Mar 2, 2026

Marshall S. Stanton - Officer

Open-market sale

Common Stock

1,513^{footnote F1}

$38.02

$58K

Footnote F1 (shares): These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

Mar 2, 2026

James P. Mackin - Officer

Open-market sale

Common Stock

14,911^{footnote F1}

$38.02

$567K

Footnote F1 (shares): These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

Mar 2, 2026

Jean F. Holloway - Officer

Open-market sale

Common Stock

2,183^{footnote F1}

$38.02

$83K

Footnote F1 (shares): These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

Mar 2, 2026

Lance A. Berry - Officer

Open-market sale

Common Stock

5,178^{footnote F1}

$38.02

$197K

Footnote F1 (shares): These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

Mar 2, 2026

John E. Davis - Officer

Open-market sale

Common Stock

2,784^{footnote F1}

$38.02

$106K

Footnote F1 (shares): These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

Feb 23, 2026

Amy Horton - Officer

Open-market sale

Common Stock

1,731^{footnote F1}

$37.59

$65K

Feb 24, 2026

Amy Horton - Officer

Open-market sale

Common Stock

830^{footnote F2}

$35.69

$30K

Feb 24, 2026

Amy Horton - Officer

Grant or award

Common Stock

5,658^{footnote F3}

$0.00

Footnote F1 (shares): These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.
Footnote F2 (shares): These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.
Footnote F3 (shares): Represents shares of restricted stock that vest 33 1/3% per year beginning on the first anniversary of the grant date, pursuant to the terms of the Equity and Cash Incentive Plan.

Filed

Filer

Relationship

Market value

Notice

Sep 10, 2026

GREEN ANDREW M

Officer

11,480

$287K

View on EDGAR

Sep 3, 2026

GREEN ANDREW M

Officer

1,493

$39K

Member	Type	Traded	Disclosed	Value range	Owner	Days to disclose	Filing
Gilbert Ray Cisneros, Jr.Democrat, CA-31	Purchase

Member

Type

Traded

Disclosed

Value range

Owner

Days to disclose

Filing

Gilbert Ray Cisneros, Jr.Democrat, CA-31

Purchase